期刊档案
CellR4
ISSN 2329-7042 · Verduci Editore · Italy
CellR4 钻石开放获取（无 APC），免版面费，投稿社区反馈审稿约 6 周，年发文 100 篇，期刊官网显示暂停或关闭投稿。
期刊官网显示暂停或关闭投稿：CellR4 has ceased its activities and is no longer accepting submissions. For more information, please visit the Press Release page. 原文 ↗出版商官网 ·
研究范围
研究范围与定位
CellR4 (Cellular Repair, Replacement, Regeneration & Reprogramming – e-ISSN: 2329-7042, Verduci International; Editor-in-Chief: Prof. Monica Montopoli) serves as a multidisciplinary, cross-platform “open source” e-journal which seeks articles related to the field of medicine, spanning from fundamental new discoveries in basic science to translational research (“bench-to-bedside”), methods and protocols, clinical trials, and identification of novel therapeutic targets. CellR4 publishes brief communications, case reports, case reports and literature review, clinical protocols, clinical trials, commentaries and perspective articles, conference proceedings, editorials, letters to the Editor, meta-analyses, meeting reports, opinion papers, original articles, systematic reviews, reviews, standard methods and operating procedures. CellR4 also serves as a trusted and authoritative platform aimed at discussing challenges and opportunities on the path to development, delivery, and clinical application of novel therapeutic options for a wide range of diseases. Topics covered by the journal include, but are not limited to, pharmacological studies, cell-based therapies, organ replacement therapies, tissue engineering, cellular reprogramming mechanisms and technologies, and regenerative pharmacology.
摘自期刊官网 Aims & Scope
主编 Monica Montopoli出版商官网
编委会国家分布：中国大陆 2 位（约 3%）；主要国家 美国 36、意大利 11、英国 3、瑞士 3、中国 2（共 60 位编委标注了国家） 编委会 ↗出版商官网 ·
分区与收录
学科分区与数据库收录
中科院期刊分区表
期刊分区表（ 2025年3月升级版）未收录
该期刊未被此版本分区表收录。
《新锐期刊分区表》（ 2026年3月发布）未收录
该期刊未被此版本分区表收录。
期刊分区表（ 2023年12月旧的升级版）未收录
该期刊未被此版本分区表收录。
数据库收录
DOAJLetPub
国际期刊预警名单：各版本均未列入LetPub
期刊官网自述收录
EBSCO catalogue、CNKI、TrendMD、Google Scholar、Semantic Scholar、Publons出版商官网
期刊官网列出的收录清单，未与各数据库逐一核对；Web of Science 各子库以上方记录为准。
不同版本、大类与小类分别展示，不将不同评价口径合并为一个分区值；投稿与考核前请确认所在机构采用的版本。
指标
影响力指标与发文规模
影响力指标
- h-index
- 0OpenAlex ·
- i10-index
- 0OpenAlex ·
- 两年平均被引
- 0OpenAlex ·
- Gold OA 文章占比
- 0%LetPub ·
发文规模
- 年发文量（出版商公布）
- 100出版商官网 ·
不同来源的统计口径与观测时间不同，页面保留各来源原值；“出版商公布”为期刊官网自述数据。
审稿与录用
审稿周期与录用情况
- 平均审稿速度（社区反馈）
- 6 WeeksLetPub ·
- 投稿到发表（期刊自报）
- 约 6 周DOAJ ·
- 评审方式
- 同行评审（未说明方式）DOAJ
社区反馈来自投稿者样本，置信度 0.5，不代表期刊承诺；“出版商公布”的时间节点定义以官网为准。
费用与开放获取
版面费与开放获取政策
钻石开放获取（无 APC）DOAJ
所有文章开放获取，且不向作者收取文章处理费。
| 来源 | 文章处理费 | 费用减免 | 许可证 | 观测时间 |
|---|---|---|---|---|
| DOAJ | 无文章处理费 | 无 | CC BY-NC-SA | |
| LetPub | 无文章处理费 | 无 | — | |
| 出版商官网 | 无文章处理费 | — | — |
- APC 费用说明 ↗DOAJ
- 开放获取声明 ↗DOAJ
- 许可与版权 ↗DOAJ
费用以期刊官网为准；不同来源的观测时间可能不同，页面保留各来源原值，不做平均。
投稿要求
文章类型与投稿政策（官网）
接收的文章类型17 种，含篇幅限制
- brief communication. Exceptions apply for the main text of Brief Communications (maximum length: 5,000 words with up to 30 references and 2 tables and/or figures), Edit正文 ≤ 5,000 词
- brief communicationsBrief Communications are short manuscripts that have important and generally preliminary data on a specific issue.未说明篇幅
- case reportCase Reports present a notable medical case or series of related cases of particular interest to the field of regenerative medicine. Case Reports can be accompa…未说明篇幅
- clinical protocolsClinical Protocols describe protocols referring to proposed or ongoing trials that have not completed participant recruitment at the time of submission.未说明篇幅
- clinical trialsClinical Trials are articles related to phase 2/3 trials that have completed participant recruitment and data analysis at the time of submission. In such articl…未说明篇幅
- commentaries and perspective articlesCommentaries and Perspective Articles are short articles that are similar to Editorials, although they provide a more detailed discussion on a specific topic.未说明篇幅
- conference proceedingsConference proceedings consist of a collection of abstracts and/or posters that were presented at an association’s conference. These articles provide opportunit…未说明篇幅
- editorialeferences and 2 tables and/or figures), Editorials (maximum length: 10,000 words with up to 30 references and 2 tables and/or figures) and O正文 ≤ 10,000 词
- lettereferences and 2 tables and/or figures). Letters are restricted to the discussion of papers already published in the journal, with a maximum of 1,000 words, one …正文 ≤ 1,000 词
- letters to the editorLetters to the Editor consists of comments on an article published in CellR4. Inclusion of Letters to the Editor in the journal is at the discretion of the Edit…未说明篇幅
- meeting reportsMeeting Reports are synopses of meetings and symposia, usually shorter than six journal pages (22000 characters including spaces). Reports must be submitted wit…未说明篇幅
- meta-analysisMeta-analyses use statistical methods to combine data from multiple and systematically selected studies. These manuscripts should be based on a rigorous methodo…未说明篇幅
- opinionrences and 2 tables and/or figures) and Opinion Papers (maximum length: 10,000 words with up to 30 references and 2 tables and/or figures). Lett正文 ≤ 10,000 词
- opinion papersOpinion Papers should be solicited by the Editor-in-Chief and deal with a controversial topic in either basic or clinical topic on which the author, a recognize…未说明篇幅
- reviewsReviews are comprehensive or narrative appraisals of research in a particular field of current interest. Reviews highlight recent advances in research, current …未说明篇幅
- standard methods and operating proceduresStandard Methods and Operating Procedures articles provide an overview of a novel method, test or Standard Operating Procedure (SOP) related to th未说明篇幅
- systematic reviewsSystematic Reviews should systematically include, appraise and summarize evidence on a specific topic. Systematic Reviews should be conducted according to the r…未说明篇幅
官网政策摘录作者资格、出版伦理、许可与版权、开放获取、同行评审
- 作者资格 Authorship and Copyright
所有作者均应对以下各项做出实质性贡献。 模型中文摘要
All authors should have made substantial contributions to all of the following:
原文 ↗出版商官网 ·- 出版伦理
本期刊使用经认证的抄袭检测软件(iThenticate®和Grammarly®)验证文章的真实性,并将每篇文章的内容与数十亿网页进行在线比对以检测重复。 模型中文摘要
Our Journal uses certified plagiarism checker softwares (iThenticate® and Grammarly®) to verify the authenticity of articles and detect duplications from each article content online against billions of web pages.
原文 ↗出版商官网 ·- 许可与版权 Authorship and Copyright
所有作者均应对以下各项做出实质性贡献。 模型中文摘要
All authors should have made substantial contributions to all of the following:
原文 ↗出版商官网 ·- 开放获取
CellR4已从按固定间隔出版完整在线期刊的传统模式转为连续出版模式,文章持续不断地发表。文章在完成制作流程后即以完全可引用的形式连同通用数字对象标识符(DOI)在线发布。 模型中文摘要
Rather than publishing conventional complete online issues at fixed intervals, CellR4 has moved to a continuous publication model, with articles being published on an ongoing basis. Articles are posted online as soon as they have completed the production process in a fully citable form associated with a universal digital object identifier (DOI).
原文 ↗出版商官网 ·- 同行评审 Peer review
CellR4 operates a single blind review process. All contributions will be initially evaluated by the Editor-in-Chief for suitability for the journal. Contributions deemed as suitable are subsequently sent to a minimum of two independent expert reviewers to assess the scientific quality of the manuscript. The journal usually recruits both internal and external reviewers for each article undergoing p…
原文 ↗出版商官网 ·
摘录来自期刊官网页面，仅保留原文片段；“模型摘要”由 Workers AI 生成并经原文校验，以官网为准。
基本信息
出版信息与官方入口
- 出版商
- Verduci Editore
- 出版国家或地区
- Italy
- 出版语言
- English
- ISSN
- 2329-7042
- 官方链接
- 期刊主页 ↗LetPub
- 作者指南 ↗LetPub
- Aims & Scope ↗LetPub
- APC 费用说明 ↗DOAJ
- 开放获取声明 ↗DOAJ
- 许可与版权 ↗DOAJ
- 评审流程 ↗LetPub
- 编委会 ↗LetPub
- 查重政策 ↗DOAJ
常见问题
关于 CellR4 的常见问题
CellR4 的审稿周期多长？
投稿社区反馈的平均审稿速度为约 6 周。文章统计只含被录用的稿件，出版商数据口径以官网为准，社区反馈来自投稿者样本，均不代表期刊承诺。
CellR4 的编委会里有中国学者吗？
期刊官网编委会页面上标注了国家的 60 位编委中，中国大陆 2 位（约 3%）；人数最多的国家是 美国（36 位）、意大利（11 位）、英国（3 位）。统计按编委会页面列出的机构国家计，仅供参考。
CellR4 被哪些数据库收录？
据 LetPub 与 DOAJ 记录，CellR4 被 DOAJ 收录。
CellR4 是开放获取期刊吗？版面费多少？
CellR4 为钻石开放获取（无 APC）。不收取文章处理费。
来源与更新
本页事实来自 LetPub、出版商官网、OpenAlex、DOAJ；每个数字旁标注来源与观测日期，冲突数据保留各来源原值。LetPub 原始详情页：查看 ↗（2026-08-25 归档）。最近更新：。